888-416-9305 info@abterrabio.com
A Decade of De Novo Antibody Sequencing Experience

A Decade of De Novo Antibody Sequencing Experience

A Decade of De Novo Antibody Sequencing Experience De novo antibody sequencing experience Have you lost your hybridoma? Is your hybridoma no longer producing? Is your hybridoma producing more than your desired antibody? Do you have a monoclonal antibody from a...
Immune Repertoire Sequencing in Human

Immune Repertoire Sequencing in Human

Immune Repertoire Sequencing in Human Immune repertoire sequencing enables deeper understanding of the adaptive immune response [1].  Abterra Biosciences has developed Reptor™, a flexible immune repertoire sequencing and analysis service. In this study, we analyzed...
Clonal Hit-Expansion Case Study

Clonal Hit-Expansion Case Study

Clonal Hit-Expansion Case Study Abterra Bio uses next-generation sequencing to mine the clonal lineage of serum-identified antibodies. This method rescues relatives of hits that are within a clone and increases diversity in your antibody discovery campaign.  Contact...
Llama Immune Repertoire Profiling

Llama Immune Repertoire Profiling

Llama Immune Repertoire Profiling Alicanto® is Abterra Biosciences’ proprietary antibody discovery platform that mines the entire immune response to identify diverse, functional antibodies. For an overview of the proteogenomic process, read more about Alicanto®....
Alicanto Antibody Discovery – Diversity

Alicanto Antibody Discovery – Diversity

Alicanto Antibody Discovery – Diversity Alicanto® is Abterra Biosciences’ proprietary antibody discovery platform that mines the entire immune response to identify diverse, functional antibodies. For an overview of the proteogenomic process, read more...

Subscribe To Our Newsletter!

Don't miss out on the latest case studies, posters, and other news.

You have Successfully Subscribed!